Drug Detail
Information about MRTX1719
Generic Name |
||
|---|---|---|
IND |
MRTX1719 | |
Brand Name (US) |
||
Manufacturer |
Bristol-Myers Squibb | |
Drug Type |
||
Delivery |
Oral | |
Approval Status |
Phase 1 | |
Indications |
Multiple | |
Overall Strategy |
Synthetic lethality | |
Strategy |
Selective inhibitor of PRMT5 | |
Drug Category |
PRMT5 Inhibitor | |
Homozygous deletion of MTAP is required.
Search for this drug/combination in: